Roche awarded priority status for early Alzheimer's detection test
Roche has been awarded breakthrough device designation by the US FDA for its Elecsys pTau217 assay designed for the early detection of Alzheimer’s disease, according to a Roche press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.